COVID-19 and Telework: An International Comparison
Journal of Quantitative Description: Digital Media · 26.04.2021 · 1
DOI: 10.51685/jqd.2021.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Quantitative Description: Digital Media, online erschienen am 26.04.2021. Verfasst von Hiroshi Ono und 1 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This paper uses identical surveys conducted in July 2020 in eight countries – U.S., U.K., Germany, Italy, Sweden, China, South Korea, and Japan – and examines teleworking within and across these eight countries. We seek to answer the following questions: (1) Which demographic and socioeconomic groups are more likely to telework? (2) Is there any association between telework and other work-related experiences such as life satisfaction and perceived productivity at work? Across countries, we observe that teleworking was higher in countries that imposed strict lockdowns, such as China, and lower in countries that had soft lockdowns, such as Japan. Within each country, there are notable differences in teleworking between low- and high-income persons, and between those employed in small versus large firms. We also find that people who used telework before COVID-19 report higher life satisfaction compared to those who started using telework for the first time after the COVID-19 outbreak.
Zitieren
APA
Ono, H., & Mori, T. (2021). COVID-19 and Telework: An International Comparison. Journal of Quantitative Description: Digital Media, 1. https://doi.org/10.51685/jqd.2021.004
Vancouver
Ono H, Mori T. COVID-19 and Telework: An International Comparison. Journal of Quantitative Description: Digital Media. 2021;1. doi:10.51685/jqd.2021.004
BibTeX
@article{Ono2021,
author = {Ono, Hiroshi and Mori, Takeshi},
title = {COVID-19 and Telework: An International Comparison},
journal = {Journal of Quantitative Description: Digital Media},
year = {2021},
volume = {1},
doi = {10.51685/jqd.2021.004}
}
EUVIMED